Radiation for Orbital Lymphoma and Thyroid Eye Disease — Low Dose, Short Course
You have been told the eye socket needs radiation, and the word alone is frightening. Both of these conditions are treated with a deliberately low dose over a short course of short daily sittings. One is a slow-growing cancer, one is not a cancer at all — and the reasons the dose stays low are different for each.
Medically reviewed by Dr. Kirti Ranjan Mohanty, Radiation Oncologist, MBBS · MD (Radiation Oncology), Senior Consultant · Last reviewed August 2026
- The dose is low on purpose — slow-growing orbital lymphoma is unusually radiation-sensitive, and thyroid eye disease only needs inflammation settled, so neither target needs a big dose.
- Around ten short sittings — commonly ten to twelve over two to three working weeks for lymphoma, around ten over a fortnight for thyroid eye disease. No admission, nothing into a vein.
- Effects are usually mild — dry, gritty eyes, pink lids, sometimes thinning of the outer brow. Cataract is the main long-term effect and is correctable with routine surgery.
- Your eye is planned around — the lens, retina and optic nerve are kept out of the high-dose region as far as the physics allows. No one can promise your sight is untouched, and this page says so.
on Panel
Survival Rate*
Treated
(800+ reviews)
Why Is the Radiation Dose So Low for Orbital Lymphoma and Thyroid Eye Disease?
Because neither target needs a large dose. Slow-growing orbital lymphoma is unusually sensitive to radiation, so a small total dose does the work. Thyroid eye disease is not a tumour at all — there the aim is to settle inflammation behind the eye. The lens, retina and optic nerve sit millimetres away, so the plan uses the least dose that works.
The lymphoma answer
Most lymphomas found in the eye socket, eyelid or tear gland are the slow-growing, marginal-zone type. They are among the most radiation-sensitive diseases in oncology. NCCN guidance lists radiotherapy on its own as the standard first treatment when the disease is confined to the orbit, with nothing systemic alongside it. The dose used is a fraction of what a solid tumour elsewhere in the body would need.
The thyroid eye disease answer
Here there is nothing to destroy. The target is the inflamed muscle and fat behind the eye in active disease, and the aim is to quieten it so the eyes move together again. A very small total dose is enough for that. It is why the course is short, and why it normally runs alongside the anti-inflammatory treatment your specialist has already prescribed rather than instead of it.
The neighbours set the ceiling
The lens, the retina, the tear gland and the optic nerve all sit within a couple of centimetres of the target. Every extra unit of dose is paid for by one of them. Modern planning shapes the beam around the orbit and keeps the lens out of the high-dose region as far as the physics allows — but the cleanest way to protect an eye is not to give it dose it does not need.
Why this matters to you
Low dose is why this treatment feels nothing like what you have read about radiation elsewhere. No sickness, no hair loss beyond possibly the outer brow and lashes, no admission, and most people carry on working. The reassurance you were given in clinic is genuine — but understand what it is reassurance about: the burden of the treatment, not a promise about the result.
Very little is written for Indian patients about radiation to the eye socket, and the two diagnoses that bring people here could hardly be more different — one is a cancer, the other is not. They are set out side by side on this page rather than blurred together, because being told “it is only a low dose” without being told why is not an explanation. Your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout, including keeping your eye specialist part of the conversation instead of a bystander to it.
Did you know?
The eye socket is one of the few places in the body where radiation is used routinely for something that is not cancer at all. Slow-growing orbital lymphoma and thyroid eye disease are planned on the same machines, by the same physicists, at doses in the same low range — for completely different reasons. If you have thyroid eye disease and you smoke, European guidance for the condition (EUGOGO) places stopping smoking ahead of every other single measure, because smokers develop more severe eye disease and respond less well to treatment for it. Position as of August 2026.
How Many Sittings Will I Need?
A short course either way. For slow-growing orbital lymphoma it is commonly around ten to twelve short daily sittings over two to three working weeks, and in selected situations far fewer. For thyroid eye disease it is commonly around ten sittings across roughly two working weeks. Your radiation oncologist confirms the exact number for your case.
| What you are asking | Orbital lymphoma | Thyroid eye disease |
|---|---|---|
| What is being treated | A slow-growing lymphoma in the eye socket, eyelid or tear gland | Inflamed muscle and fat behind the eye, while the disease is still active |
| Is it cancer | Yes — usually the indolent, slow-moving kind | No. It is an autoimmune condition, not a tumour |
| Typical number of sittings | Commonly around ten to twelve; sometimes only two in selected cases | Commonly around ten |
| Spread over | Two to three working weeks | About two working weeks |
| Length of each visit | Minutes — most of it positioning | Minutes — most of it positioning |
| Given alongside | Usually nothing systemic when the disease is confined to the orbit | The anti-inflammatory course your eye or thyroid specialist has prescribed |
| When you notice a change | Swelling and fullness usually settle over weeks to a few months | Slowly — weeks to months, with the fullest effect late |
| Admission needed | No. Day visits, home straight afterwards | No. Day visits, home straight afterwards |
The very short two-sitting schedule for lymphoma is real, and when it is used it is used deliberately — most often where the priority is relieving symptoms quickly, where the orbit has already been irradiated once, or where someone is frail. It is a considered choice, not a cut-price version of the full course. Ask your radiation oncologist which schedule they have planned and why; the answer tells you a great deal about how they are thinking about your case.
Missing one day is not a disaster, but do not casually skip sittings. The course is designed as a whole, not as ten separate appointments. If work or travel is going to make daily attendance hard, say so at the planning visit rather than in week two.
Are the Side Effects Mild?
Mostly yes, and this is one of the gentler treatments in radiation oncology. Expect dry, gritty eyes, pink or tight-feeling lids, and possible thinning of the outer eyebrow or lashes. What matters longer term is cataract, and far more rarely injury to the retina or optic nerve. Nobody can promise your sight will be untouched.
Through the course
Dry, gritty eyes are the commonest complaint, because the tear gland lies inside the treated area. Lids can look pink and feel tight. In thyroid eye disease a short worsening of swelling in the first week or two is expected rather than alarming, and it is one reason the prescribed anti-inflammatory course usually runs alongside. You are never radioactive. There is no sickness, and no hair loss anywhere except at the edge of the treated area.
Months and years later
Cataract is the main long-term effect and it is an openly acknowledged trade, not a hidden one: the lens receives a small dose and may cloud earlier than it otherwise would. It is correctable with routine surgery. Dry eye can persist and may need long-term lubrication your team advises. Retinal injury is uncommon at these doses and optic-nerve injury from the treatment itself is rare — but rare is not never, which is exactly why the plan is drawn as tightly as it is.
The second-cancer question
Any radiation carries a small theoretical risk of a new cancer arising in the treated area many years afterwards. At the low doses used around the orbit this has not emerged as a common problem, and orbital radiotherapy has been in use for decades. The risk is not zero, and it weighs more heavily the younger you are. There is no dependable figure to quote here, and anyone giving you a precise percentage is guessing. Position as of August 2026.
Where more caution is needed
- Diabetes with changes at the back of the eye. The clearest reason to think hard, and in thyroid eye disease often a reason to avoid radiotherapy altogether. Mention your diabetes at the first appointment and bring any recent retinal report with you.
- Poorly controlled blood pressure with retinal changes. Handled with the same caution, for the same reason.
- Pregnancy, or the possibility of it. Radiotherapy is not given in pregnancy. Say so before anything is planned, not on the first treatment day.
- Both orbits involved. Common in thyroid eye disease, and it happens in lymphoma too. It changes the planning conversation rather than the answer.
- Younger patients. Not a bar, but the long-term questions carry more weight, so the decision should be reasoned out with you in full rather than presented as routine.
Do not wait for your next scheduled appointment if your vision starts to fade, colours look washed out, or you develop a new constant ache behind the eye with worsening sight. That combination is assessed the same day. Contact your eye specialist, or call CION on 1800 202 8726.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Understand the Plan Before You Sign the Consent Form
Bring your scans, your eye clinic notes and any biopsy report. We will tell you plainly what the treatment is aimed at and what it is not.
Is Orbital Lymphoma the Same Thing as Thyroid Eye Disease?
No. They are unrelated conditions that happen to be treated with the same tool. Orbital lymphoma is a cancer of immune cells growing in the eye socket. Thyroid eye disease is autoimmune inflammation driven by the same process that affects the thyroid gland. Both can cause a bulging, uncomfortable eye, which is why they are sometimes confused early on.
| Where they differ | Orbital lymphoma | Thyroid eye disease |
|---|---|---|
| What is happening | Immune cells forming a slow-growing mass in the orbit | Autoimmune inflammation of the muscle and fat behind the eye |
| How it usually shows up | A painless salmon-pink swelling, a fullness, a lid that will not sit right, sometimes a gradually bulging eye | Grittiness, redness, lid retraction, bulging of both eyes, double vision |
| How the diagnosis is made | Imaging plus a biopsy — the tissue diagnosis is what decides treatment | Clinical assessment of activity plus thyroid tests and imaging; no biopsy |
| Who leads the plan | Radiation oncologist with a haemato-oncologist and your ophthalmologist | Ophthalmologist and endocrinologist, with the radiation oncologist joining in |
| Aim of radiotherapy | To clear the disease in the orbit and keep it controlled locally | To settle inflammation, mainly for double vision and stiff eye movement |
| Staging or activity check first | Yes — the rest of the body is checked before treating the orbit alone | Yes — treatment only helps while the disease is still active |
| What follow-up looks like | Long-term lymphoma surveillance plus eye reviews | Eye reviews and thyroid follow-up; corrective surgery considered later |
One difference is worth spelling out. Lymphoma needs a tissue diagnosis before anyone treats it, and it needs the rest of the body checked, because treating the orbit alone is only right when the disease is only in the orbit. Thyroid eye disease needs neither, but it does need an honest assessment of whether the disease is still active — radiotherapy given to burnt-out disease adds risk without adding benefit. If you have thyroid eye disease specifically, the deeper page on orbital radiotherapy for Graves’ eye disease covers timing, appearance and the surgical sequence in full.
What Actually Happens, From Referral to Last Sitting?
A decision made jointly with your eye specialist, then a planning scan with a light mask moulded to your face, then a few days while the plan is drawn, then short daily visits for about two to three weeks. Nothing goes into a vein. You are not admitted. You drive or travel home afterwards.
- The diagnosis is settled first. For lymphoma that means a biopsy and staging scans, because radiotherapy to the orbit alone is only the right plan when the disease is confined to the orbit. For thyroid eye disease it means your ophthalmologist judging how active the disease still is.
- A joint decision, not a solo one. The radiation oncologist, your ophthalmologist and — depending on the diagnosis — a haemato-oncologist or your endocrinologist agree that radiotherapy is the right next step and what it is aimed at. Ask them to say that aim out loud in front of you.
- The planning visit. A scan is taken with you lying in the treatment position. A light plastic mask is moulded to your face so your head sits identically every day; millimetres matter this close to an eye. Some people find the mask the hardest part — say so early and the team will work with you on it.
- The plan is drawn. The target volume is outlined and the lens, retina, tear gland and optic nerve are pulled out of the high-dose region as far as the physics allows. This step happens without you and usually takes a few days. It is the step that protects your eye.
- Daily sittings. Short visits on working days — commonly around ten, occasionally two, sometimes a little more. You feel nothing while the beam is on. Most of each appointment is spent lining you up, not treating you.
- Your prescribed treatment continues. In thyroid eye disease the anti-inflammatory course generally runs alongside, precisely because a short early flare is expected. Do not stop it or change the dose on your own.
- The benefit arrives slowly. This is the part people are not warned about. Swelling settles and eye movement improves over weeks to months, not days. Judging the treatment on the last day of the course is judging it far too early.
- Follow-up. Lymphoma is followed long term, with eye reviews alongside. Thyroid eye disease is reviewed by your ophthalmologist and endocrinologist, and any corrective surgery is discussed only once things have been quiet for months.
What Should I Ask and Do Around the Treatment?
Three things do most of the work. Get the aim of the treatment stated clearly. Protect the surface of your eyes from the first day rather than the day it starts stinging. And get the cost and insurance position in writing before you begin, not halfway through.
Before it starts
Tell the team about diabetes, any retinal problem, high blood pressure, previous radiation near the head, and whether you are or might be pregnant. Bring your scans, your biopsy report if you have one, and any retinal report. Ask two questions: what is this treatment aimed at in my case, and how many sittings have you planned and why. Ask for the cost in writing and check what your insurance covers.
Through the course
Use the eye lubrication your team advises on a schedule, not only when your eyes feel dry. Wear sunglasses outdoors and keep the treated area out of direct sun. Sleep with your head raised on an extra pillow if the lids are puffy in the mornings. If double vision makes driving unsafe, arrange a lift for the fortnight instead of pushing through it. Keep every appointment.
For the months after
Keep your eye reviews even when things feel better — cataract and dry eye are picked up there, and both are manageable when found early. Report any change in vision rather than waiting for the next appointment. If you smoke and you have thyroid eye disease, stopping is the single measure that keeps working long after the machine is switched off. Keep thyroid follow-up so your levels stay steady.
On cost: the figure depends on the technique used and the number of sessions planned, so ask for it in writing before you start, along with what your policy will and will not carry — insurers treat a cancer indication and a non-cancer indication very differently. Any number quoted to you is indicative, as of August 2026, and should be confirmed against your own plan and your own policy.
Your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout. That coordination is the practical value here — orbital cases fail most often not because the physics is hard, but because the eye specialist, the physician and the radiation oncologist never speak to each other directly.
Talk to a Radiation Oncologist About Your Eye
A short conversation is usually enough to tell you whether the plan you have been offered fits your diagnosis and your stage.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Radiation for Orbital Lymphoma and Thyroid Eye Disease — Your Questions Answered
Why is the radiation dose so low for orbital lymphoma and thyroid eye disease?
Because neither target needs a large dose. The slow-growing marginal-zone lymphomas that usually appear in the eye socket are among the most radiation-sensitive diseases in oncology, so a small total dose does the work, and NCCN guidance lists radiotherapy alone as the standard first treatment when the disease is confined to the orbit. Thyroid eye disease is not a tumour at all; the aim there is to settle inflammation in the muscle and fat behind the eye, and a very small dose is enough for that. The second reason is geography. The lens, retina, tear gland and optic nerve all sit within a couple of centimetres of the target, so every extra unit of dose is paid for by one of them.
How many radiation sittings will I need for orbital lymphoma or thyroid eye disease?
A short course either way. For slow-growing orbital lymphoma it is commonly around ten to twelve short daily sittings spread over two to three working weeks, and in selected situations only two. For thyroid eye disease it is commonly around ten sittings across roughly two working weeks. Each visit takes minutes, and most of that is spent lining your head up rather than treating you. Nothing is given into a vein and you are not admitted. Your radiation oncologist confirms the exact schedule for your case, and it is worth asking which schedule they have chosen and why, because the answer tells you how they are thinking about your situation.
Are the side effects of orbital radiation mild?
Mostly yes, and this is one of the gentler treatments in radiation oncology. Dry, gritty eyes are the commonest complaint, because the tear gland lies inside the treated area. Lids can look pink and feel tight, and the outer eyebrow or lashes may thin. In thyroid eye disease a short worsening of swelling in the first week or two is expected rather than alarming. There is no sickness, no hair loss beyond the edge of the treated area, and you are never radioactive. Longer term the main issue is cataract, which is correctable with routine surgery. Retinal injury is uncommon at these doses and optic-nerve injury from the treatment itself is rare.
Will radiation to my eye socket affect my eyesight?
No honest doctor will promise that your sight will be untouched, and you should be wary of anyone who does. What can be said is that the plan is built around protecting vision: the target volume is drawn tightly, the lens, retina and optic nerve are pulled out of the high-dose region as far as the physics allows, and the total dose used is deliberately low. Most people come through orbital radiotherapy without losing vision. Cataract is the commonest sight-related effect and is treatable. If your vision fades, colours look washed out, or you develop a new constant ache behind the eye with worsening sight, that is assessed the same day rather than at your next appointment.
Is orbital lymphoma the same illness as thyroid eye disease?
No. They are unrelated conditions that happen to be treated with the same tool. Orbital lymphoma is a cancer of immune cells forming a slow-growing mass in the eye socket, eyelid or tear gland, and it needs a biopsy plus staging scans before anyone treats it. Thyroid eye disease is autoimmune inflammation of the muscle and fat behind the eye, driven by the same process that affects the thyroid gland, and it needs no biopsy but does need an honest assessment of whether the disease is still active. Both can cause a bulging, uncomfortable eye, which is why they are sometimes confused early on.
I do not have cancer, so why am I being treated at a cancer centre?
Because the machines, and the physicists who plan on them, sit inside cancer services. Radiation is a tool, not a diagnosis, and a referral for orbital radiotherapy says nothing on its own about cancer. Thyroid eye disease is one of a short list of conditions that are not cancer but are treated this way. What you receive is a low total dose, aimed at a small area behind the eye, over about a fortnight, with nothing systemic from us. Your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout, including keeping your eye specialist and your physician in the loop.
Where is the treatment given, and what will it cost?
CION Cancer Clinics does not own or operate a linear accelerator or any other radiotherapy machine. Your radiotherapy is delivered at an NABH-accredited partner centre, while CION coordinates your treatment plan, your oncology team and your care throughout, from the planning scan to follow-up. On cost, the figure depends on the technique used and the number of sessions planned, so ask for it in writing before you begin. Check what your policy covers as well, because insurers treat a cancer indication and a non-cancer indication very differently. Any figure quoted to you is indicative, as of August 2026, and should be confirmed against your own plan and policy.